{
  "id": 565,
  "text": "A complete or partial response was observed in $9 0 .2 \\%$ of patients with FIGO stage IB1.No cases of grade 3 or 4 hematological or gastrointestinal toxicity were observed.After 8 years of follow-up, the OS was not statistically significant between the control group and the NACT group.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A complete or partial response was observed in $9 0 .2 \\%$ of patients with FIGO stage IB1.No cases of grade 3 or 4 hematological or gastrointestinal toxicity were observed.After 8 years of follow-up, the OS was not statistically significant between the control group and the NACT group.\n\n<question>: ",
  "ChatGPT_response_0": "FIGO I B1阶段的患者中，约有90.2%的患者出现了完全或部分的反应。另外，根据8年的随访结果显示，对照组和新辅助化疗组的总生存率之间并不存在显著性差异。",
  "query": "FIGO I B1阶段的患者中，有多少百分比的患者出现了完全或部分的反应？同时，8年的随访结果显示对照组和新辅助化疗组的总生存率是否存在显著性差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: FIGO I B1阶段的患者中，有多少百分比的患者出现了完全或部分的反应？同时，8年的随访结果显示对照组和新辅助化疗组的总生存率是否存在显著性差异？\n\n<reference text>: A complete or partial response was observed in $9 0 .2 \\%$ of patients with FIGO stage IB1.No cases of grade 3 or 4 hematological or gastrointestinal toxicity were observed.After 8 years of follow-up, the OS was not statistically significant between the control group and the NACT group.\n\n<reply>: ",
  "response": "FIGO I B1阶段的患者中，约有90.2%的患者出现了完全或部分的反应。另外，根据8年的随访结果显示，对照组和新辅助化疗组的总生存率之间并不存在显著性差异。"
}